Cargando…
High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial
Autores principales: | El-Damanawi, R, Lee, M, Harris, T, Cowley, L B, Bond, S, Pavey, H, Sandford, R N, Wilkinson, I B, Karet Frankl, F E, Hiemstra, T F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133781/ https://www.ncbi.nlm.nih.gov/pubmed/31956915 http://dx.doi.org/10.1093/qjmed/hcz326 |
Ejemplares similares
-
High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial
por: El-Damanawi, R, et al.
Publicado: (2020) -
Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial
por: El-Damanawi, Ragada, et al.
Publicado: (2018) -
Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey
por: El-Damanawi, Ragada, et al.
Publicado: (2017) -
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease
por: El-Damanawi, Ragada, et al.
Publicado: (2021) -
Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic
por: Robinson, Caroline, et al.
Publicado: (2012)